These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32086703)

  • 1. The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring.
    Jones AE; King JB; Kim K; Witt DM
    J Thromb Thrombolysis; 2020 Oct; 50(3):739-745. PubMed ID: 32086703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes.
    Davis KA; Joseph J; Nisly SA
    J Thromb Thrombolysis; 2020 Aug; 50(2):457-461. PubMed ID: 31915998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a Direct Oral Anticoagulant Population Management Tool on Anticoagulation Therapy Monitoring in Clinical Practice.
    Valencia D; Spoutz P; Stoppi J; Kibert JL; Allen A; Parra D; Hough A
    Ann Pharmacother; 2019 Aug; 53(8):806-811. PubMed ID: 30854862
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimization of DOAC management services in a centralized anticoagulation clinic.
    Sylvester KW; Chen A; Lewin A; Fanikos J; Goldhaber SZ; Connors JM
    Res Pract Thromb Haemost; 2022 Mar; 6(3):e12696. PubMed ID: 35541695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.
    Feldman DN; Wang TY; Chen AY; Swaminathan RV; Kim LK; Wong SC; Minutello RM; Bergman G; Singh HS; Madias C
    J Am Heart Assoc; 2019 Apr; 8(8):e011606. PubMed ID: 30955406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Oral Anticoagulant Use After Transcatheter Aortic Valve Replacement: A Case Series.
    Hendricks AK; Nei SD; Greason KL; Scott RA
    J Cardiovasc Pharmacol; 2020 Jan; 75(1):41-44. PubMed ID: 31633585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment.
    Ting C; Rhoten M; Dempsey J; Nichols H; Fanikos J; Ruff CT
    Clin Appl Thromb Hemost; 2021; 27():1076029620987900. PubMed ID: 33517715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation.
    Arbel R; Sergienko R; Hammerman A; Dotan-Greenberg S; Batat E; Avnery O; Greenberg D; Ellis MH
    Heart; 2019 Oct; 105(19):1487-1492. PubMed ID: 30971403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Frymire E; Khan S; Johnson AP;
    Thromb Res; 2019 Oct; 182():12-19. PubMed ID: 31434018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding and thrombotic outcomes associated with postoperative use of direct oral anticoagulants after open peripheral artery bypass procedures.
    Obi AT; Thompson JR; Beaulieu RJ; Sutzko DC; Osborne N; Albright J; Gallagher KA; Henke PK
    J Vasc Surg; 2020 Dec; 72(6):1996-2005.e4. PubMed ID: 32278573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
    Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
    Yanagisawa D; Abe K; Amano H; Komatsuda S; Honda T; Manabe D; Yamamoto H; Kozuma K; Kodashima S; Asaoka Y; Yamamoto T; Tanaka A
    PLoS One; 2021; 16(11):e0260585. PubMed ID: 34843582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation.
    Bendayan M; Mardigyan V; Williamson D; Chen-Tournoux A; Eintracht S; Rudski L; MacNamara E; Blostein M; Afilalo M; Afilalo J
    J Am Geriatr Soc; 2021 Apr; 69(4):1012-1018. PubMed ID: 33432589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation.
    Wang CL; Wu VC; Huang YT; Chen YL; Chu PH; Kuo CF; Wen MS; Chang SH
    J Thromb Thrombolysis; 2021 Jan; 51(1):58-66. PubMed ID: 32409936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service.
    Ashjian E; Kurtz B; Renner E; Yeshe R; Barnes GD
    Am J Health Syst Pharm; 2017 Apr; 74(7):483-489. PubMed ID: 28336758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Barra ME; Fanikos J; Connors JM; Sylvester KW; Piazza G; Goldhaber SZ
    Am J Med; 2016 Nov; 129(11):1198-1204. PubMed ID: 27341955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.